Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Nov 12 - Nov 17
The 10/3 vial holds 10 mg tesamorelin and 3 mg ipamorelin (13 mg total), so it is GHRH-dominant
That's a single receptor target
In T2DM, insulin resistance leads to poor glucose control, while in PD, insulin resistance within the brain can exacerbate neurodegeneration by impairing glucose uptake and metabolism
However, all health insurance policies and health benefit plans contain exclusions and limitations
Possible during the first few months of treatment, especially during dose escalation
US$ 29.25
US$ 22.41
US$ 29.09
US$ 20.51
